These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18395431)

  • 1. Dissolution rate enhancement of the novel antitumoral beta-lapachone by solvent change precipitation of microparticles.
    Cunha-Filho MS; Martínez-Pacheco R; Landín M
    Eur J Pharm Biopharm; 2008 Aug; 69(3):871-7. PubMed ID: 18395431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast dissolving β-lapachone particles and tablets: an approach using surface adsorption technique.
    Cunha-Filho MS; Martínez-Pacheco R; Landin M
    Drug Dev Ind Pharm; 2012 Jul; 38(7):866-71. PubMed ID: 22074117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
    Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
    Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
    Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
    AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.
    Mangas-Sanjuan V; Gutiérrez-Nieto J; Echezarreta-López M; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M; Landin M
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):795-806. PubMed ID: 26602766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced dissolution of oxcarbazepine microcrystals using a static mixer process.
    Douroumis D; Fahr A
    Colloids Surf B Biointerfaces; 2007 Oct; 59(2):208-14. PubMed ID: 17588726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process.
    Won DH; Kim MS; Lee S; Park JS; Hwang SJ
    Int J Pharm; 2005 Sep; 301(1-2):199-208. PubMed ID: 16024189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin.
    Ghorab MK; Adeyeye MC
    Pharm Dev Technol; 2001 Aug; 6(3):305-14. PubMed ID: 11485172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
    Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
    Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of azithromycin nanosuspensions by reactive precipitation method.
    Hou CD; Wang JX; Le Y; Zou HK; Zhao H
    Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs.
    Rasenack N; Hartenhauer H; Müller BW
    Int J Pharm; 2003 Mar; 254(2):137-45. PubMed ID: 12623189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.
    Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F
    Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs.
    Rasenack N; Müller BW
    Pharm Res; 2002 Dec; 19(12):1894-900. PubMed ID: 12523671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs.
    Rogers TL; Gillespie IB; Hitt JE; Fransen KL; Crowl CA; Tucker CJ; Kupperblatt GB; Becker JN; Wilson DL; Todd C; Broomall CF; Evans JC; Elder EJ
    Pharm Res; 2004 Nov; 21(11):2048-57. PubMed ID: 15587927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.